Top Story

S-1 noninferior to UFT/LV for stage III colon cancer

August 29, 2014

Adjuvant chemotherapy with the oral fluoropyrimidine derivative S-1 conferred similar DFS rates as tegafur-uracil plus leucovorin among patients with stage III colon cancer, according to results of a randomized phase 3 study.

The findings suggest S-1 could be a new treatment option in this setting, researchers wrote.

In the Journals

Long-term central venous catheter use increased infection risk in older patients with cancer

August 12, 2014
Older adult patients with cancer who experienced long-term exposure to central venous catheters demonstrated an increased risk for infection, according to results of a…
In the Journals

Herpes zoster vaccine continued to protect after chemotherapy

August 8, 2014
The herpes zoster vaccine remained effective among recipients who later underwent chemotherapy, according to data published in Clinical Infectious Diseases.“The…

Top 8 lessons learned at ASCO 2014

June 25, 2014
The theme of this year’s ASCO Annual Meeting, “Science and Society,” emphasized patient-centered focus — looking at the full implications of a…
CME CNE

Treatment Decision-Making through the Spectrum of MDS: Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

8/20/2014
MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
CME

Applying Imaging, Biomarkers, and Immunotherapy in the Management of NSCLC

This activity is supported by an educational grant from Genentech, Inc.

8/7/2014
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, but the numerous subtypes make this disease…
More »

Filter By:

In the Journals

S-1 noninferior to UFT/LV for stage III colon cancer

August 29, 2014
Adjuvant chemotherapy with the oral fluoropyrimidine derivative S-1 conferred similar DFS rates as tegafur-uracil plus leucovorin among patients with…
In the Journals

Long-term central venous catheter use increased infection risk in older patients with cancer

August 12, 2014
Older adult patients with cancer who experienced long-term exposure to central venous catheters demonstrated an increased risk for infection…
In the Journals

Herpes zoster vaccine continued to protect after chemotherapy

August 8, 2014
The herpes zoster vaccine remained effective among recipients who later underwent chemotherapy, according to data published in Clinical Infectious

Top 8 lessons learned at ASCO 2014

June 25, 2014
The theme of this year’s ASCO Annual Meeting, “Science and Society,” emphasized patient-centered focus — looking at the full…
Meeting News Coverage Perspective

Obesity linked to mortality in premenopausal, ER-positive early breast cancer

May 15, 2014
Obesity was an independent risk factor for breast cancer mortality among premenopausal women with ER-positive disease, according to results of a…
Meeting News Coverage

Study: Routine biopsy during vertebroplasty helps reveal cancer in older patients with VCF

April 9, 2014
SAN FRANCISCO — Patients not suspected of having cancer in the spine or thought to be in remission were readily identified through routine…
Case Challenges

A 72-year-old man develops engraftment syndrome after autologous HSCT

HemOnc Today, January 25, 2014
Tim McCarthy, MD
This case focuses on a 72-year-old man with a medical history significant for multiple myeloma, diagnosed 2 years prior.
Meeting News Coverage

Alternating, sequential combination drug administration feasible in elderly with multiple myeloma

December 11, 2013
NEW ORLEANS — The combination of bortezomib, melphalan and prednisone alternately or sequentially added to lenalidomide plus dexamethasone was…
In the Journals Perspective

Trastuzumab increased heart failure risk in older patients with breast cancer

November 25, 2013
Older patients with breast cancer treated with trastuzumab were at increased risk for congestive heart failure, according to study results. This risk…
In the Journals

Four-cycle ABVD unsuitable for older patients with Hodgkin’s lymphoma

April 24, 2013
Four cycles of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine led to a significant dose reduction, delay in treatment, toxicity…
More Headlines »